Australia vs Luxembourg: Access to anti-retroviral drugs, female
Australia
87.0%
in 2023
Luxembourg
87.0%
in 2024
Australia rank
45th
Luxembourg rank
45th
Access to anti-retroviral drugs, female over time
- Australia
- Luxembourg
How they compare
Australia currently reports 87.0% against 87.0% in Luxembourg, a difference of 0.0%.
The two have swapped places 4 times across 24 shared years of data; in 2000 it was Australia ahead.
Australia ranks 45th and Luxembourg ranks 45th of 141 countries.
Australia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.7% | 43.3% | 8.4% | Australia |
| 2010s | 66.4% | 64.1% | 2.3% | Australia |
| 2020s | 81.5% | 78.5% | 3.0% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Australia or Luxembourg?
- Australia, at 87.0% against 87.0% in Luxembourg as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Australia and Luxembourg?
- 0.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Luxembourg?
- 24 years are reported by both, from 2000 to 2023.
- How do Australia and Luxembourg rank globally for access to anti-retroviral drugs, female?
- Australia ranks 45th and Luxembourg ranks 45th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.